Clinical Trial Update: A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa [Phase 3]

View source ↗

Summary

Phase 3 bioequivalence study comparing two ciprofloxacin/dexamethasone otic formulations for otitis externa was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Externa

Drugs mentioned

• Ciprofloxacin/Dexamethasone Otic Suspension (ciprofloxacin/dexamethasone)

Snippet

Sponsor: Par Pharmaceutical, Inc. | Conditions: Otitis Externa | Phase 3 | Status: TERMINATED